Terry J. Rosen

Terry J. Rosen is a declared insider of Arcus Biosciences, Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 19 March 2018 to 23 January 2026, the count stands at 57 filings.

In open-market terms, that means 23 purchases worth €3.2M on one side and 16 sales worth €1.9M on the other. Taken together, the purchases exceed the sales by €1.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 9 share grants.

Half of the purchases are above €67k and half below. Of 23 purchases, 23 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 26 January 2026: a share grant, in Arcus Biosciences, Inc. The latest purchase dates back some time: it was published 619 days ago, on 27 February 2025. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.